biOasis Technologies Inc is a Life Sciences Company committed to the development of novel diagnostic molecular products for Alzheimer’s Disease and other neurological diseases and the pursuit of delivering a variety of compounds, including therapeutics, across the Blood-Brain Barrier, using our patented Blood Brain Barrier Compound Delivery Platform.